RUNX3 and central nervous system cancer: In summary, our study provides new insights into the role of miR-19a/b in human glioma and confirms that miR-19 is able to inhibit RUNX3 expression level through directly binding to the 3′UTR region of RUNX3 which medicates the suppression of β-catenin/TCF4 transcription.